|Articles|June 5, 2013
The Data Can Speak for Itself
Applied Clinical Trials Editorial talks with CluePoints' Founder Marc Buyse about the history of CluePoints as well as the role of biostatistics in clinical trials
Advertisement
In this interview Applied Clinical Trials Editorial Director Lisa Henderson talks with CluePoints' Founder Marc Buyse. They discuss the history of CluePoints as well as the role of biostatistics: "The Data Can Speak for Itself
SPOTLIGHT EVENT
Cambridge, MassachusettsDownload Brochure
RELATED
-
- Risk-Based Approach to Monitoring
- Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?More in Risk-Based Monitoring
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
5